MYGN 8-K 2026-09-16
MYRIAD GENETICS INC (MYGN) 8-K dated 2026-09-16 — accession 0000899923-26-000079.
MYRIAD GENETICS INC (MYGN) is a diagnostics & research company listed on NASDAQ.
MYRIAD GENETICS INC filed a 8-K on 2026-09-16. Accession 0000899923-26-000079.
This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported MYGN revenue for 2025-12-31 was $824.5M. Net income was -$365.9M. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. MYGN currently screens at market cap $413.7M.
Not investment advice. The MYGN SEC hub lists recent forms. The stock page is the research view.